Day One Biopharmaceuticals (DAWN) Earnings Date & Reports
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
DAWN is expected to report earnings to rise 18.37% to -41 cents per share on August 12
Q2'25
Est.
$-0.41
Q1'25
Beat
by $0.07
Q4'24
Missed
by $0.17
Q3'24
Beat
by $0.70
Q2'24
Beat
by $0.70
The last earnings report on May 06 showed earnings per share of -34 cents, beating the estimate of -41 cents. With 1.34M shares outstanding, the current market capitalization sits at 653.79M.